Chemical Component Summary

NameCOCAINE
Identifiersmethyl (1R,2R,3S,5S,8S)-8-methyl-3-(phenylcarbonyloxy)-8-azabicyclo[3.2.1]octane-2-carboxylate
FormulaC17 H21 N O4
Molecular Weight303.353
TypeNON-POLYMER
Isomeric SMILESC[N@]1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)c3ccccc3)C(=O)OC
InChIInChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1
InChIKeyZPUCINDJVBIVPJ-LJISPDSOSA-N

Chemical Details

Formal Charge0
Atom Count43
Chiral Atom Count4
Bond Count45
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB00907 
NameCocaine
Groups
  • approved
  • illicit
DescriptionAn alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.
Synonyms
  • Methyl benzoylecgonine
  • beta-Cocain
  • L-Cocain
  • Neurocaine
  • (-)-Cocaine
Brand Names
  • Cocaine Hydrochloride
  • Cocaine Hydrochloride Nasal
  • Cocaine Hydrochloride Topical Sol 10%
  • PMS-cocaine Hydrochloride Topical Sol 4%
  • Numbrino
IndicationFor the introduction of local (topical) anesthesia of accessible mucous membranes of the oral, laryngeal and nasal cavities.
Categories
  • Agents producing tachycardia
  • Agents that reduce seizure threshold
  • Alkaloids
  • Analgesics and Anesthetics
  • Anesthetics
ATC-Code
  • S01HA01
  • S02DA02
  • N01BC01
  • R02AD03
CAS number50-36-2

Drug Targets

NameTarget SequencePharmacological ActionActions
Sodium-dependent dopamine transporterMSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNP...unknowninhibitor
Sodium-dependent noradrenaline transporterMLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRD...unknowninhibitor
Sodium channel proteinMEQTVLVPPGPDSFNFFTRESLAAIERRIAEEKAKNPKPDKKDDDENGPK...unknowninhibitor
Sodium-dependent serotonin transporterMETTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAV...unknowninhibitor
Muscarinic acetylcholine receptor M1MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISF...unknownantagonist
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL370805
PubChem 446220
ChEMBL CHEMBL370805
ChEBI CHEBI:27958
CCDC/CSD COCAIN10